{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:41:26Z","timestamp":1793155286404,"version":"4.5.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2020-MS-01"],"award-info":[{"award-number":["2020-MS-01"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Province","doi-asserted-by":"publisher","award":["2020D01A122"],"award-info":[{"award-number":["2020D01A122"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00415-022-11247-z","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T05:02:31Z","timestamp":1656738151000},"page":"5272-5282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Paraneoplastic syndrome in neuroophthalmology"],"prefix":"10.1007","volume":"269","author":[{"given":"Longdan","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7414-0773","authenticated-orcid":false,"given":"Chao","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,2]]},"reference":[{"key":"11247_CR1","doi-asserted-by":"publisher","first-page":"R173","DOI":"10.1530\/erc-17-0036","volume":"24","author":"GK Dimitriadis","year":"2017","unstructured":"Dimitriadis GK, Angelousi A, Weickert MO, Randeva HS, Kaltsas G, Grossman A (2017) Paraneoplastic endocrine syndromes. Endocr Relat Cancer 24:R173-r190. https:\/\/doi.org\/10.1530\/erc-17-0036","journal-title":"Endocr Relat Cancer"},{"key":"11247_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01676-x","author":"P Sarkar","year":"2021","unstructured":"Sarkar P, Mehtani A, Gandhi HC, Bhalla JS, Tapariya S (2021) Paraneoplastic ocular syndrome: a pandora\u2019s box of underlying malignancies. Eye (Lond). https:\/\/doi.org\/10.1038\/s41433-021-01676-x","journal-title":"Eye (Lond)"},{"key":"11247_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s12038-020-00128-0","author":"L Lorusso","year":"2021","unstructured":"Lorusso L, Precone V, Hart IK, Giometto B, Pezzani R, Ngonga GK, Ngonga G, Paolacci S, Ferrari D, Ricevuti G, Marshall E, Bertelli M (2021) Immunophenotypical characterization of paraneoplastic neurological syndrome patients: a multicentric study. J Biosci. https:\/\/doi.org\/10.1007\/s12038-020-00128-0","journal-title":"J Biosci"},{"key":"11247_CR4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.23736\/s2784-8671.20.06675-4","volume":"156","author":"D Didona","year":"2021","unstructured":"Didona D, Diz G, Joly P (2021) Paraneoplastic autoimmune multiorgan syndrome. Ital J Dermatol Venerol 156:174\u2013183. https:\/\/doi.org\/10.23736\/s2784-8671.20.06675-4","journal-title":"Ital J Dermatol Venerol"},{"key":"11247_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11912-018-0721-y","volume":"20","author":"RS Grativvol","year":"2018","unstructured":"Grativvol RS, Cavalcante WCP, Castro LHM, Nitrini R, Simabukuro MM (2018) Updates in the diagnosis and treatment of paraneoplastic neurologic syndromes. Curr Oncol Rep 20:92. https:\/\/doi.org\/10.1007\/s11912-018-0721-y","journal-title":"Curr Oncol Rep"},{"key":"11247_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/wco.0000000000000475","volume":"30","author":"JC Antoine","year":"2017","unstructured":"Antoine JC, Camdessanch\u00e9 JP (2017) Paraneoplastic neuropathies. Curr Opin Neurol 30:513\u2013520. https:\/\/doi.org\/10.1097\/wco.0000000000000475","journal-title":"Curr Opin Neurol"},{"key":"11247_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8110490","author":"J Prze\u017adziecka-Do\u0142yk","year":"2020","unstructured":"Prze\u017adziecka-Do\u0142yk J, Brzecka A, Ejma M, Misiuk-Hoj\u0142o M, Torres Solis LF, Sol\u00eds Herrera A, Somasundaram SG, Kirkland CE, Aliev G (2020) Ocular paraneoplastic syndromes. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines8110490","journal-title":"Biomedicines"},{"key":"11247_CR8","first-page":"14","volume":"66","author":"P Ojha","year":"2018","unstructured":"Ojha P, Jagiasi K, Chheda A, Soni G, Peddawad D, Kadam N, Patil S (2018) Does the tempo and pattern of neurological syndrome help diagnose paraneoplastic etiology? J Assoc Physicians India 66:14\u201318","journal-title":"J Assoc Physicians India"},{"key":"11247_CR9","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/0002-9394(76)90125-2","volume":"81","author":"RA Sawyer","year":"1976","unstructured":"Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF (1976) Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 81:606\u2013613. https:\/\/doi.org\/10.1016\/0002-9394(76)90125-2","journal-title":"Am J Ophthalmol"},{"key":"11247_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12886-018-0948-2","volume":"18","author":"F Hoogewoud","year":"2018","unstructured":"Hoogewoud F, Butori P, Blanche P, Br\u00e9zin AP (2018) Cancer-associated retinopathy preceding the diagnosis of cancer. BMC Ophthalmol 18:285. https:\/\/doi.org\/10.1186\/s12886-018-0948-2","journal-title":"BMC Ophthalmol"},{"key":"11247_CR11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4872","volume":"11","author":"S Naramala","year":"2019","unstructured":"Naramala S, Ahmad J, Adapa S, Gavini F, Konala VM (2019) Case series of cancer-associated retinopathy (CAR). Cureus 11:e4872. https:\/\/doi.org\/10.7759\/cureus.4872","journal-title":"Cureus"},{"key":"11247_CR12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.29399\/npa.25097","volume":"58","author":"C Sayman","year":"2021","unstructured":"Sayman C, Tireli H, G\u00fcrleyik GM (2021) Cancer-associated retinopathy in patients with newly diagnosed breast tumor. Noro Psikiyatr Ars 58:278\u2013282. https:\/\/doi.org\/10.29399\/npa.25097","journal-title":"Noro Psikiyatr Ars"},{"key":"11247_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000511189","volume":"7","author":"S Wagley","year":"2021","unstructured":"Wagley S, Tran TM, Mallory PW, Lee MS, Armbrust KR, Trautman B, Montezuma SR (2021) Cancer-associated retinopathy due to clear cell renal carcinoma. Ocul Oncol Pathol 7:31\u201335. https:\/\/doi.org\/10.1159\/000511189","journal-title":"Ocul Oncol Pathol"},{"key":"11247_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4103\/ojo.ojo_352_20","volume":"14","author":"E Dimitriou","year":"2021","unstructured":"Dimitriou E, Chatzirallis A, Katopodis S, Theodossiadis G, Theodossiadis P, Chatziralli I (2021) Cancer-associated retinopathy 4 years after surgery for ovarian cancer. Oman J Ophthalmol 14:108\u2013111. https:\/\/doi.org\/10.4103\/ojo.ojo_352_20","journal-title":"Oman J Ophthalmol"},{"key":"11247_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.108317","volume":"210","author":"G Adamus","year":"2020","unstructured":"Adamus G, Champaigne R, Yang S (2020) Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy. Clin Immunol 210:108317. https:\/\/doi.org\/10.1016\/j.clim.2019.108317","journal-title":"Clin Immunol"},{"key":"11247_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12886-018-0861-8","volume":"18","author":"P Tyagi","year":"2018","unstructured":"Tyagi P, Santiago C (2018) New features in MEK retinopathy. BMC Ophthalmol 18:221. https:\/\/doi.org\/10.1186\/s12886-018-0861-8","journal-title":"BMC Ophthalmol"},{"key":"11247_CR17","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.17219\/acem\/73860","volume":"27","author":"M Kordy\u015b","year":"2018","unstructured":"Kordy\u015b M, Prze\u017adziecka-Do\u0142yk J, Turno-Kr\u0119cicka A, Misiuk-Hoj\u0142o M (2018) Immunopathogenesis of ophthalmological paraneoplastic syndromes: recent findings. Adv Clin Exp Med 27:1431\u20131439. https:\/\/doi.org\/10.17219\/acem\/73860","journal-title":"Adv Clin Exp Med"},{"key":"11247_CR18","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/cmr.0000000000000769","volume":"31","author":"S Lan","year":"2021","unstructured":"Lan S, Cui Z, Yin Q, Liu Z, Liang L, He H, Liu H, Guo Z, Yu Y, Wu D (2021) Prospective study of clinical characteristics of melanoma patients with retinopathy caused by a high-dose interferon \u03b1-2b. Melanoma Res 31:550\u2013554. https:\/\/doi.org\/10.1097\/cmr.0000000000000769","journal-title":"Melanoma Res"},{"key":"11247_CR19","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1016\/j.jcjo.2020.01.006","volume":"55","author":"F Evoy","year":"2020","unstructured":"Evoy F, Lafortune J (2020) First case of melanoma-associated retinopathy with conjunctival melanoma. Can J Ophthalmol 55:e153\u2013e155. https:\/\/doi.org\/10.1016\/j.jcjo.2020.01.006","journal-title":"Can J Ophthalmol"},{"key":"11247_CR20","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1167\/iovs.17-21443","volume":"58","author":"RM Duvoisin","year":"2017","unstructured":"Duvoisin RM, Haley TL, Ren G, Strycharska-Orczyk I, Bonaparte JP, Morgans CW (2017) Autoantibodies in melanoma-associated retinopathy recognize an epitope conserved between TRPM1 and TRPM3. Invest Ophthalmol Vis Sci 58:2732\u20132738. https:\/\/doi.org\/10.1167\/iovs.17-21443","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"11247_CR21","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1365-2133.2005.06480.x","volume":"152","author":"G Ladewig","year":"2005","unstructured":"Ladewig G, Reinhold U, Thirkill CE, Kerber A, Tilgen W, Pf\u00f6hler C (2005) Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV. Br J Dermatol 152:931\u2013938. https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06480.x","journal-title":"Br J Dermatol"},{"key":"11247_CR22","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1001\/archophthalmol.2009.311","volume":"127","author":"Y Lu","year":"2009","unstructured":"Lu Y, Jia L, He S, Hurley MC, Leys MJ, Jayasundera T, Heckenlively JR (2009) Melanoma-associated retinopathy: a paraneoplastic autoimmune complication. Arch Ophthalmol 127:1572\u20131580. https:\/\/doi.org\/10.1001\/archophthalmol.2009.311","journal-title":"Arch Ophthalmol"},{"key":"11247_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00041327-200109000-00004","volume":"21","author":"JL Keltner","year":"2001","unstructured":"Keltner JL, Thirkill CE, Yip PT (2001) Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuroophthalmol 21:173\u2013187. https:\/\/doi.org\/10.1097\/00041327-200109000-00004","journal-title":"J Neuroophthalmol"},{"key":"11247_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40942-021-00300-0","volume":"7","author":"AR Gameiro Filho","year":"2021","unstructured":"Gameiro Filho AR, Sturzeneker G, Rodriguez EEC, Maia A, Morales MC, Belfort RN (2021) Acute exudative polymorphous paraneoplastic vitelliform maculopathy (AEPPVM) associated with choroidal melanoma. Int J Retina Vitr 7:27. https:\/\/doi.org\/10.1186\/s40942-021-00300-0","journal-title":"Int J Retina Vitr"},{"key":"11247_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ophtha.2017.07.020","volume":"125","author":"I Barbazetto","year":"2018","unstructured":"Barbazetto I, Dansingani KK, Dolz-Marco R, Giovannini A, Piccolino FC, Agarwal A, Lima LH, Vianna RN, Yannuzzi LA (2018) Idiopathic acute exudative polymorphous vitelliform maculopathy: clinical spectrum and multimodal imaging characteristics. Ophthalmology 125:75\u201388. https:\/\/doi.org\/10.1016\/j.ophtha.2017.07.020","journal-title":"Ophthalmology"},{"key":"11247_CR26","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3928\/15428877-20120712-01","volume":"43","author":"SA Al-Dahmash","year":"2012","unstructured":"Al-Dahmash SA, Shields CL, Bianciotto CG, Witkin AJ, Witkin SR, Shields JA (2012) Acute exudative paraneoplastic polymorphous vitelliform maculopathy in five cases. Ophthalmic Surg Lasers Imaging 43:366\u2013373. https:\/\/doi.org\/10.3928\/15428877-20120712-01","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"11247_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/archopht.1990.01070060075053","volume":"108","author":"JD Gass","year":"1990","unstructured":"Gass JD, Gieser RG, Wilkinson CP, Beahm DE, Pautler SE (1990) Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma. Arch Ophthalmol 108:527\u2013533. https:\/\/doi.org\/10.1001\/archopht.1990.01070060075053","journal-title":"Arch Ophthalmol"},{"key":"11247_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.691686","volume":"8","author":"N Tong","year":"2021","unstructured":"Tong N, Wang L, Wang N, Zhou Z (2021) Bilateral diffuse uveal melanocytic proliferation secondary to rectal adenocarcinoma: a case report and literature review. Front Med (Lausanne) 8:691686. https:\/\/doi.org\/10.3389\/fmed.2021.691686","journal-title":"Front Med (Lausanne)"},{"key":"11247_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jneuroim.2019.03.001","volume":"330","author":"Z Liu","year":"2019","unstructured":"Liu Z, Jiao L, Qiu Z, Da Y, Tang Y, Lin Y, Li D, Huang J, Kang X, Dong H (2019) Clinical characteristics of patients with paraneoplastic myelopathy. J Neuroimmunol 330:136\u2013142. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.03.001","journal-title":"J Neuroimmunol"},{"key":"11247_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ajoc.2018.03.013","volume":"10","author":"G Uludag","year":"2018","unstructured":"Uludag G, Onay A, Onal S (2018) Unilateral paraneoplastic optic disc edema and retinal periphlebitis in pineal germinoma. Am J Ophthalmol Case Rep 10:236\u2013239. https:\/\/doi.org\/10.1016\/j.ajoc.2018.03.013","journal-title":"Am J Ophthalmol Case Rep"},{"key":"11247_CR31","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2147\/cia.S202102","volume":"14","author":"J Yuan","year":"2019","unstructured":"Yuan J, Jia Z, Qin W, Hu W (2019) Paraneoplastic neuromyelitis optica spectrum disorder associated with breast cancer. Clin Interv Aging 14:1039\u20131044. https:\/\/doi.org\/10.2147\/cia.S202102","journal-title":"Clin Interv Aging"},{"key":"11247_CR32","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/j.athoracsur.2017.10.015","volume":"105","author":"DC Wiener","year":"2018","unstructured":"Wiener DC, Kaplan TB, Bravo-I\u00f1iguez CE, Miller J, Berkowitz AL, Jaklitsch MT (2018) Paraneoplastic neuromyelitis optica spectrum disorder as presentation of esophageal adenocarcinoma. Ann Thorac Surg 105:e133\u2013e135. https:\/\/doi.org\/10.1016\/j.athoracsur.2017.10.015","journal-title":"Ann Thorac Surg"},{"key":"11247_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ophtha.2019.09.012","volume":"127","author":"DA Cohen","year":"2020","unstructured":"Cohen DA, Bhatti MT, Pulido JS, Lennon VA, Dubey D, Flanagan EP, Pittock SJ, Klein CJ, Chen JJ (2020) Collapsin response-mediator protein 5-associated retinitis, vitritis, and optic disc edema. Ophthalmology 127:221\u2013229. https:\/\/doi.org\/10.1016\/j.ophtha.2019.09.012","journal-title":"Ophthalmology"},{"key":"11247_CR34","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/bjophthalmol-2018-312046","volume":"103","author":"Q Xu","year":"2019","unstructured":"Xu Q, Du W, Zhou H, Zhang X, Liu H, Song H, Wang X, Wei S (2019) Distinct clinical characteristics of paraneoplastic optic neuropathy. Br J Ophthalmol 103:797\u2013801. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312046","journal-title":"Br J Ophthalmol"},{"key":"11247_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/WNO.0b013e3182699b2a","volume":"33","author":"TL Slamovits","year":"2013","unstructured":"Slamovits TL, Posner JB, Reidy DL, Thirkill CE, Keltner JL (2013) Pancreatic neuroendocrine paraneoplastic optic neuropathy: confirmation with antibody to optic nerve and hepatic metastasis. J Neuroophthalmol 33:21\u201325. https:\/\/doi.org\/10.1097\/WNO.0b013e3182699b2a","journal-title":"J Neuroophthalmol"},{"key":"11247_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ana.20529","volume":"58","author":"SJ Pittock","year":"2005","unstructured":"Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, Stephan CL, Kim KK, Kilimann MW, Lennon VA (2005) Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol 58:96\u2013107. https:\/\/doi.org\/10.1002\/ana.20529","journal-title":"Ann Neurol"},{"key":"11247_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/00005792-198007000-00006","volume":"59","author":"PA Bardwick","year":"1980","unstructured":"Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL (1980) Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine (Baltimore) 59:311\u2013322. https:\/\/doi.org\/10.1097\/00005792-198007000-00006","journal-title":"Medicine (Baltimore)"},{"key":"11247_CR38","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/ajh.26240","volume":"96","author":"A Dispenzieri","year":"2021","unstructured":"Dispenzieri A (2021) POEMS syndrome: 2021 Update on diagnosis, risk-stratification, and management. Am J Hematol 96:872\u2013888. https:\/\/doi.org\/10.1002\/ajh.26240","journal-title":"Am J Hematol"},{"key":"11247_CR39","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/jamaoncol.2021.0586","volume":"7","author":"J Khouri","year":"2021","unstructured":"Khouri J, Nakashima M, Wong S (2021) Update on the diagnosis and treatment of POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome: a review. JAMA Oncol 7:1383\u20131391. https:\/\/doi.org\/10.1001\/jamaoncol.2021.0586","journal-title":"JAMA Oncol"},{"key":"11247_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40942-020-00278-1","volume":"7","author":"AR Carey","year":"2021","unstructured":"Carey AR, Jeyaseelan P (2021) Peripheral retinal leakage in POEMS syndrome. Int J Retina Vitr 7:6. https:\/\/doi.org\/10.1186\/s40942-020-00278-1","journal-title":"Int J Retina Vitr"},{"key":"11247_CR41","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.oftal.2019.05.013","volume":"94","author":"A Ortiz Zapata","year":"2019","unstructured":"Ortiz Zapata A, C\u00e1rdenas PL, Acu\u00f1a MF, Peralta \u00c1lvarez M, Ortiz Zapata J, Pizarro Imaicela B (2019) Neuro-ophthalmological manifestations of POEMS syndrome. Arch Soc Esp Oftalmol (Engl Ed) 94:495\u2013499. https:\/\/doi.org\/10.1016\/j.oftal.2019.05.013","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"key":"11247_CR42","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1182\/bloodadvances.2020001865","volume":"4","author":"J Feng","year":"2020","unstructured":"Feng J, Gao XM, Zhao H, He TH, Zhang CL, Shen KN, Zhang L, Cao XX, Qian M, Zhou DB, Li J (2020) Ischemic stroke in patients with POEMS syndrome. Blood Adv 4:3427\u20133434. https:\/\/doi.org\/10.1182\/bloodadvances.2020001865","journal-title":"Blood Adv"},{"key":"11247_CR43","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000486","volume":"5","author":"M Pihan","year":"2018","unstructured":"Pihan M, Keddie S, D\u2019Sa S, Church AJ, Yong KL, Reilly MM, Lunn MP (2018) Raised VEGF: High sensitivity and specificity in the diagnosis of POEMS syndrome. Neurol Neuroimmunol Neuroinflamm 5:e486. https:\/\/doi.org\/10.1212\/nxi.0000000000000486","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11247_CR44","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/s0272-6386(99)70386-0","volume":"34","author":"M Soubrier","year":"1999","unstructured":"Soubrier M, Sauron C, Souweine B, Larroche C, Wechsler B, Guillevin L, Piette JC, Rousset H, Deteix P (1999) Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Am J Kidney Dis 34:633\u2013638. https:\/\/doi.org\/10.1016\/s0272-6386(99)70386-0","journal-title":"Am J Kidney Dis"},{"key":"11247_CR45","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18046","volume":"13","author":"M Abdelahad","year":"2021","unstructured":"Abdelahad M, Pearson R, Mauri B, Fenton K, Savu C (2021) Heart Failure With Cardiogenic Shock As A Manifestation Of Untreated POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes) syndrome. Cureus 13:e18046. https:\/\/doi.org\/10.7759\/cureus.18046","journal-title":"Cureus"},{"key":"11247_CR46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/hon.2135","volume":"33","author":"RT Cui","year":"2015","unstructured":"Cui RT, Yu SY, Huang XS, Zhang JT, Tian CL, Dou LP, Pu CQ (2015) Incidence and risk factors of pleural effusions in patients with POEMS syndrome. Hematol Oncol 33:80\u201384. https:\/\/doi.org\/10.1002\/hon.2135","journal-title":"Hematol Oncol"},{"key":"11247_CR47","doi-asserted-by":"publisher","first-page":"794","DOI":"10.17235\/reed.2021.8027\/2021","volume":"113","author":"Y Tang","year":"2021","unstructured":"Tang Y, Cai R, Qiao Z (2021) POEMS syndrome: an uncommon cause of peritoneal effusion. Rev Esp Enferm Dig 113:794. https:\/\/doi.org\/10.17235\/reed.2021.8027\/2021","journal-title":"Rev Esp Enferm Dig"},{"key":"11247_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/icb.0000000000000735","volume":"15","author":"R Tomita","year":"2021","unstructured":"Tomita R, Sekiryu T, Shintake H, Saito K (2021) Retinal microstructure in poems syndrome. Retin Cases Brief Rep 15:71\u201376. https:\/\/doi.org\/10.1097\/icb.0000000000000735","journal-title":"Retin Cases Brief Rep"},{"key":"11247_CR49","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00415-018-9138-7","volume":"266","author":"SY Oh","year":"2019","unstructured":"Oh SY, Kim JS, Dieterich M (2019) Update on opsoclonus-myoclonus syndrome in adults. J Neurol 266:1541\u20131548. https:\/\/doi.org\/10.1007\/s00415-018-9138-7","journal-title":"J Neurol"},{"key":"11247_CR50","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/b978-0-444-52910-7.00042-8","volume":"112","author":"M Pike","year":"2013","unstructured":"Pike M (2013) Opsoclonus-myoclonus syndrome. Handb Clin Neurol 112:1209\u20131211. https:\/\/doi.org\/10.1016\/b978-0-444-52910-7.00042-8","journal-title":"Handb Clin Neurol"},{"key":"11247_CR51","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/practneurol-2020-002875","volume":"21","author":"AW McHattie","year":"2021","unstructured":"McHattie AW, Wei D, Ahmad H, Nirmalananthan N (2021) Paraneoplastic opsoclonus-myoclonus-ataxia syndrome secondary to ovarian cancer. Pract Neurol 21:437\u2013438. https:\/\/doi.org\/10.1136\/practneurol-2020-002875","journal-title":"Pract Neurol"},{"key":"11247_CR52","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1097\/wno.0000000000001384","volume":"42","author":"AA Jones","year":"2021","unstructured":"Jones AA, Chen T (2021) Delayed opsoclonus-myoclonus syndrome after ovarian teratoma resection. J Neuroophthalmol 42:e450-451. https:\/\/doi.org\/10.1097\/wno.0000000000001384","journal-title":"J Neuroophthalmol"},{"key":"11247_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/children8110965","author":"M Auconi","year":"2021","unstructured":"Auconi M, Papetti L, Ruscitto C, Ferilli MAN, Ursitti F, Sforza G, Vigevano F, Valeriani M (2021) Opsoclonus-myoclonus syndrome in children and adolescents: a therapeutic challenge. Children (Basel). https:\/\/doi.org\/10.3390\/children8110965","journal-title":"Children (Basel)"},{"key":"11247_CR54","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1007\/s00330-020-07587-x","volume":"31","author":"R Kumar","year":"2021","unstructured":"Kumar R, Vankadari K, Mittal BR, Bansal D, Trehan A, Sahu JK, Sankhyan N (2021) Diagnostic values of (68)Ga-labelled DOTANOC PET\/CT imaging in pediatric patients presenting with paraneoplastic opsoclonus myoclonus ataxia syndrome. Eur Radiol 31:4587\u20134594. https:\/\/doi.org\/10.1007\/s00330-020-07587-x","journal-title":"Eur Radiol"},{"key":"11247_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102862","volume":"50","author":"S Adhikari","year":"2021","unstructured":"Adhikari S, Thuringer A, Maali L, Jassam Y (2021) Opsoclonus myoclonus syndrome in a postpartum period. Mult Scler Relat Disord 50:102862. https:\/\/doi.org\/10.1016\/j.msard.2021.102862","journal-title":"Mult Scler Relat Disord"},{"key":"11247_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/1570159x16666180917105033","volume":"17","author":"H Mitoma","year":"2019","unstructured":"Mitoma H, Manto M, Hampe CS (2019) Immune-mediated cerebellar ataxias: practical guidelines and therapeutic challenges. Curr Neuropharmacol 17:33\u201358. https:\/\/doi.org\/10.2174\/1570159x16666180917105033","journal-title":"Curr Neuropharmacol"},{"key":"11247_CR57","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/s1474-4422(11)70245-9","volume":"10","author":"MJ Titulaer","year":"2011","unstructured":"Titulaer MJ, Lang B, Verschuuren JJ (2011) Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol 10:1098\u20131107. https:\/\/doi.org\/10.1016\/s1474-4422(11)70245-9","journal-title":"Lancet Neurol"},{"key":"11247_CR58","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/wno.0000000000000258","volume":"36","author":"JD Young","year":"2016","unstructured":"Young JD, Leavitt JA (2016) Lambert-eaton myasthenic syndrome: ocular signs and symptoms. J Neuroophthalmol 36:20\u201322. https:\/\/doi.org\/10.1097\/wno.0000000000000258","journal-title":"J Neuroophthalmol"},{"key":"11247_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/s-2000-6829","volume":"20","author":"JJ Barton","year":"2000","unstructured":"Barton JJ, Fouladvand M (2000) Ocular aspects of myasthenia gravis. Semin Neurol 20:7\u201320. https:\/\/doi.org\/10.1055\/s-2000-6829","journal-title":"Semin Neurol"},{"key":"11247_CR60","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/mus.24745","volume":"52","author":"FY Chiou-Tan","year":"2015","unstructured":"Chiou-Tan FY, Gilchrist JM (2015) Repetitive nerve stimulation and single-fiber electromyography in the evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: review of recent literature. Muscle Nerve 52:455\u2013462. https:\/\/doi.org\/10.1002\/mus.24745","journal-title":"Muscle Nerve"},{"key":"11247_CR61","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1007\/s00415-017-8541-9","volume":"264","author":"B Schoser","year":"2017","unstructured":"Schoser B, Eymard B, Datt J, Mantegazza R (2017) Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer. J Neurol 264:1854\u20131863. https:\/\/doi.org\/10.1007\/s00415-017-8541-9","journal-title":"J Neurol"},{"key":"11247_CR62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jocn.2019.04.003","volume":"65","author":"Y Liu","year":"2019","unstructured":"Liu Y, Xi J, Zhou L, Wu H, Yue D, Zhu W, Lin J, Lu J, Zhao C, Qiao K (2019) Clinical characteristics and long term follow-up of Lambert-Eaton myasthenia syndrome in patients with and without small cell lung cancer. J Clin Neurosci 65:41\u201345. https:\/\/doi.org\/10.1016\/j.jocn.2019.04.003","journal-title":"J Clin Neurosci"},{"key":"11247_CR63","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nmd.2014.08.006","volume":"25","author":"A Okada","year":"2015","unstructured":"Okada A, Koike H, Nakamura T, Motomura M, Sobue G (2015) Efficacy of intravenous immunoglobulin for treatment of Lambert-Eaton myasthenic syndrome without anti-presynaptic P\/Q-type voltage-gated calcium channel antibodies: a case report. Neuromuscul Disord 25:70\u201372. https:\/\/doi.org\/10.1016\/j.nmd.2014.08.006","journal-title":"Neuromuscul Disord"},{"key":"11247_CR64","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/b978-0-444-63432-0.00024-4","volume":"133","author":"J Verschuuren","year":"2016","unstructured":"Verschuuren J, Strijbos E, Vincent A (2016) Neuromuscular junction disorders. Handb Clin Neurol 133:447\u2013466. https:\/\/doi.org\/10.1016\/b978-0-444-63432-0.00024-4","journal-title":"Handb Clin Neurol"},{"key":"11247_CR65","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1111\/ene.14820","volume":"28","author":"R \u00c1lvarez-Velasco","year":"2021","unstructured":"\u00c1lvarez-Velasco R, Guti\u00e9rrez-Guti\u00e9rrez G, Trujillo JC, Mart\u00ednez E, Segovia S, Arribas-Velasco M, Fern\u00e1ndez G, Paradas C, V\u00e9lez-G\u00f3mez B, Casasnovas C, Nedkova V, Guerrero-Sola A, Ramos-Fransi A, Mart\u00ednez-Pi\u00f1eiro A, Pardo J, Sevilla T, G\u00f3mez-Caravaca MT, L\u00f3pez de Munain A, Jeric\u00f3 I, Pelayo-Negro AL, Mart\u00edn MA, Morgado Y, Mendoza MD, P\u00e9rez-P\u00e9rez H, Rojas-Garc\u00eda R, Turon-Sans J, Querol L, Gallardo E, Illa I, Cort\u00e9s-Vicente E (2021) Clinical characteristics and outcomes of thymoma-associated myasthenia gravis. Eur J Neurol 28:2083\u20132091. https:\/\/doi.org\/10.1111\/ene.14820","journal-title":"Eur J Neurol"},{"key":"11247_CR66","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1080\/01676830.2018.1550790","volume":"38","author":"S Kumar","year":"2019","unstructured":"Kumar S, Diamond T (2019) Paraneoplastic syndrome - a rare but treatable cause of non-thyroid-related extraocular muscle enlargement. Orbit 38:468\u2013473. https:\/\/doi.org\/10.1080\/01676830.2018.1550790","journal-title":"Orbit"},{"key":"11247_CR67","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1212\/con.0000000000000788","volume":"25","author":"L Gordon","year":"2019","unstructured":"Gordon L, Dinkin M (2019) Paraneoplastic syndromes in neuro-ophthalmology. Continuum (Minneap Minn) 25:1401\u20131421. https:\/\/doi.org\/10.1212\/con.0000000000000788","journal-title":"Continuum (Minneap Minn)"},{"key":"11247_CR68","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1111\/ene.14799","volume":"28","author":"M Janssen","year":"2021","unstructured":"Janssen M, van Broekhoven F, Sillevis Smitt P, Frens M, van der Geest J (2021) The use of eye-movement recording in patients with anti-Hu antibody-associated paraneoplastic neurological syndromes to objectively determine extent and course of disease. Eur J Neurol 28:2126\u20132132. https:\/\/doi.org\/10.1111\/ene.14799","journal-title":"Eur J Neurol"},{"issue":"Suppl 3","key":"11247_CR69","doi-asserted-by":"publisher","first-page":"S296","DOI":"10.1016\/s1353-8020(08)70019-1","volume":"13","author":"PC van Broekhoven","year":"2007","unstructured":"van Broekhoven PC, Frens MA, Sillevis Smitt PA, van der Geest JN (2007) Eye movements as a marker for cerebellar damage in paraneoplastic neurological syndromes. Parkinsonism Relat Disord 13(Suppl 3):S296-300. https:\/\/doi.org\/10.1016\/s1353-8020(08)70019-1","journal-title":"Parkinsonism Relat Disord"},{"key":"11247_CR70","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1749-6632.2011.06113.x","volume":"1233","author":"SH Wray","year":"2011","unstructured":"Wray SH, Dalmau J, Chen A, King S, Leigh RJ (2011) Paraneoplastic disorders of eye movements. Ann N Y Acad Sci 1233:279\u2013284. https:\/\/doi.org\/10.1111\/j.1749-6632.2011.06113.x","journal-title":"Ann N Y Acad Sci"},{"key":"11247_CR71","doi-asserted-by":"publisher","first-page":"7076385","DOI":"10.1155\/2022\/7076385","volume":"2022","author":"CB Sun","year":"2022","unstructured":"Sun CB, Liu GH, Xiao Q, Zhao YN, Ren Q (2022) Serum and cerebrospinal fluid testing in optic neuropathy patients with malignant tumors. Dis Markers 2022:7076385. https:\/\/doi.org\/10.1155\/2022\/7076385","journal-title":"Dis Markers"},{"key":"11247_CR72","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00401-001-0498-0","volume":"103","author":"F Bernal","year":"2002","unstructured":"Bernal F, Graus F, Pifarr\u00e9 A, Saiz A, Benyahia B, Ribalta T (2002) Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis. Acta Neuropathol 103:509\u2013515. https:\/\/doi.org\/10.1007\/s00401-001-0498-0","journal-title":"Acta Neuropathol"},{"key":"11247_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2021.107578","volume":"39","author":"MD Krasowski","year":"2021","unstructured":"Krasowski MD, Dolezal A, Steussy BW, Gailey MP, Darbro BW (2021) Data on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center. Data Brief 39:107578. https:\/\/doi.org\/10.1016\/j.dib.2021.107578","journal-title":"Data Brief"},{"key":"11247_CR74","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jim.2013.02.017","volume":"391","author":"P Maat","year":"2013","unstructured":"Maat P, Brouwer E, Hulsenboom E, VanDuijn M, Schreurs MW, Hooijkaas H, Smitt PA (2013) Multiplex serology of paraneoplastic antineuronal antibodies. J Immunol Methods 391:125\u2013132. https:\/\/doi.org\/10.1016\/j.jim.2013.02.017","journal-title":"J Immunol Methods"},{"key":"11247_CR75","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.clim.2018.12.007","volume":"199","author":"L Seluk","year":"2019","unstructured":"Seluk L, Taliansky A, Yonath H, Gilburd B, Amital H, Shoenfeld Y, Kivity S (2019) A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values. Clin Immunol 199:29\u201336. https:\/\/doi.org\/10.1016\/j.clim.2018.12.007","journal-title":"Clin Immunol"},{"key":"11247_CR76","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.autrev.2009.01.002","volume":"8","author":"G Adamus","year":"2009","unstructured":"Adamus G (2009) Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmun Rev 8:410\u2013414. https:\/\/doi.org\/10.1016\/j.autrev.2009.01.002","journal-title":"Autoimmun Rev"},{"key":"11247_CR77","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.ajo.2004.12.104","volume":"139","author":"RG Weleber","year":"2005","unstructured":"Weleber RG, Watzke RC, Shults WT, Trzupek KM, Heckenlively JR, Egan RA, Adamus G (2005) Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol 139:780\u2013794. https:\/\/doi.org\/10.1016\/j.ajo.2004.12.104","journal-title":"Am J Ophthalmol"},{"key":"11247_CR78","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.bulcan.2019.03.011","volume":"106","author":"E El Rassy","year":"2019","unstructured":"El Rassy E, Assi T, Kattan J, Pavlidis N (2019) Paraneoplastic syndromes in cancers of unknown primary: An unknown field for oncologists. Bull Cancer 106:590\u2013603. https:\/\/doi.org\/10.1016\/j.bulcan.2019.03.011","journal-title":"Bull Cancer"},{"key":"11247_CR79","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/s0025-6196(12)60050-0","volume":"68","author":"AM Patel","year":"1993","unstructured":"Patel AM, Davila DG, Peters SG (1993) Paraneoplastic syndromes associated with lung cancer. Mayo Clin Proc 68:278\u2013287. https:\/\/doi.org\/10.1016\/s0025-6196(12)60050-0","journal-title":"Mayo Clin Proc"},{"key":"11247_CR80","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ygyno.2017.06.025","volume":"146","author":"M Viau","year":"2017","unstructured":"Viau M, Renaud MC, Gr\u00e9goire J, Sebastianelli A, Plante M (2017) Paraneoplastic syndromes associated with gynecological cancers: a systematic review. Gynecol Oncol 146:661\u2013671. https:\/\/doi.org\/10.1016\/j.ygyno.2017.06.025","journal-title":"Gynecol Oncol"},{"key":"11247_CR81","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/MCP.0b013e328347bdba","volume":"17","author":"SC Yeung","year":"2011","unstructured":"Yeung SC, Habra MA, Thosani SN (2011) Lung cancer-induced paraneoplastic syndromes. Curr Opin Pulm Med 17:260\u2013268. https:\/\/doi.org\/10.1097\/MCP.0b013e328347bdba","journal-title":"Curr Opin Pulm Med"},{"key":"11247_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100653","volume":"43","author":"T Li","year":"2020","unstructured":"Li T, Timmins HC, Lazarus HM, Park SB (2020) Peripheral neuropathy in hematologic malignancies: past, present and future. Blood Rev 43:100653. https:\/\/doi.org\/10.1016\/j.blre.2020.100653","journal-title":"Blood Rev"},{"key":"11247_CR83","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/01.wco.0000044765.39452.2d","volume":"15","author":"A Demopoulos","year":"2002","unstructured":"Demopoulos A, DeAngelis LM (2002) Neurologic complications of leukemia. Curr Opin Neurol 15:691\u2013699. https:\/\/doi.org\/10.1097\/01.wco.0000044765.39452.2d","journal-title":"Curr Opin Neurol"},{"key":"11247_CR84","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.4103\/ijo.IJO_1416_18","volume":"67","author":"D Kasongole","year":"2019","unstructured":"Kasongole D, Raval V, Mruthyunjaya P, Narayanan R (2019) Multimodal imaging in non-paraneoplastic autoimmune retinopathy. Indian J Ophthalmol 67:1171\u20131173. https:\/\/doi.org\/10.4103\/ijo.IJO_1416_18","journal-title":"Indian J Ophthalmol"},{"key":"11247_CR85","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3928\/23258160-20161130-09","volume":"47","author":"DQ Li","year":"2016","unstructured":"Li DQ, Golding J, Glittenberg C, Choudhry N (2016) Multimodal imaging features in acute exudative paraneoplastic polymorphous vitelliform maculopathy. Ophthalmic Surg Lasers Imaging Retina 47:1143\u20131146. https:\/\/doi.org\/10.3928\/23258160-20161130-09","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"11247_CR86","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/jamaophthalmol.2019.0284","volume":"137","author":"E Karatsai","year":"2019","unstructured":"Karatsai E, Robson AG, Taylor SRJ (2019) Outcomes associated with sustained-release intraocular fluocinolone implants in a case of melanoma-associated retinopathy treated without systemic immunosuppression. JAMA Ophthalmol 137:564\u2013567. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.0284","journal-title":"JAMA Ophthalmol"},{"key":"11247_CR87","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3341\/kjo.2018.0091","volume":"33","author":"MS Kim","year":"2019","unstructured":"Kim MS, Hong HK, Park KH, Woo SJ (2019) Intravitreal dexamethasone implant with plasma autoantibody monitoring for cancer-associated retinopathy. Korean J Ophthalmol 33:298\u2013300. https:\/\/doi.org\/10.3341\/kjo.2018.0091","journal-title":"Korean J Ophthalmol"},{"key":"11247_CR88","doi-asserted-by":"publisher","DOI":"10.1097\/icb.0000000000001008","author":"TP Gemperline","year":"2020","unstructured":"Gemperline TP, Smith BT (2020) Treatment of bilateral diffuse uveal melanocytic proliferation with intravitreal steroid implants. Retin Cases Brief Rep. https:\/\/doi.org\/10.1097\/icb.0000000000001008","journal-title":"Retin Cases Brief Rep"},{"key":"11247_CR89","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7534","volume":"12","author":"R Myadam","year":"2020","unstructured":"Myadam R, Gohar A (2020) Testicular seminoma presenting with bilateral blindness: looking beyond the eye. Cureus 12:e7534. https:\/\/doi.org\/10.7759\/cureus.7534","journal-title":"Cureus"},{"key":"11247_CR90","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/09273948.2019.1681471","volume":"29","author":"L Ramos-Ruperto","year":"2021","unstructured":"Ramos-Ruperto L, Busca-Arenzana C, Boto-de Los Bueis A, Schlincker A, Arnalich-Fern\u00e1ndez F, Robles-Marhuenda \u00c1 (2021) Cancer-associated retinopathy and treatment with intravenous immunoglobulin therapy. A seldom used approach? Ocul Immunol Inflamm 29:399\u2013402. https:\/\/doi.org\/10.1080\/09273948.2019.1681471","journal-title":"Ocul Immunol Inflamm"},{"key":"11247_CR91","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10633-017-9605-y","volume":"135","author":"D Roels","year":"2017","unstructured":"Roels D, Ueno S, Talianu CD, Draganova D, Kondo M, Leroy BP (2017) Unilateral cancer-associated retinopathy: diagnosis, serology and treatment. Doc Ophthalmol 135:233\u2013240. https:\/\/doi.org\/10.1007\/s10633-017-9605-y","journal-title":"Doc Ophthalmol"},{"key":"11247_CR92","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/icb.0000000000000604","volume":"13","author":"HS Sandhu","year":"2019","unstructured":"Sandhu HS, Kolomeyer AM, Lau MK, Shields CL, Schuchter LM, Nichols CW, Aleman TS (2019) Acute exudative paraneoplastic polymorphous vitelliform maculopathy during vemurafenib and pembrolizumab treatment for metastatic melanoma. Retin Cases Brief Rep 13:103\u2013107. https:\/\/doi.org\/10.1097\/icb.0000000000000604","journal-title":"Retin Cases Brief Rep"},{"key":"11247_CR93","doi-asserted-by":"publisher","DOI":"10.1097\/icb.0000000000001040","author":"D Kemels","year":"2020","unstructured":"Kemels D, Ten Berge JC, Jacob J, Schauwvlieghe PP (2020) The role of Checkpoint inhibitors in paraneoplastic acute exudative polymorphous vitelliform maculopathy: report of two cases. Retin Cases Brief Rep. https:\/\/doi.org\/10.1097\/icb.0000000000001040","journal-title":"Retin Cases Brief Rep"},{"key":"11247_CR94","doi-asserted-by":"publisher","DOI":"10.1097\/icb.0000000000001081","author":"SA Hamdan","year":"2020","unstructured":"Hamdan SA, Breazzano MP, Daniels AB (2020) Triple therapy with rituximab, IVIg and intravitreal corticosteroids for melanoma-associated retinopathy (MAR): TTRIIC does the trick. Retin Cases Brief Rep. https:\/\/doi.org\/10.1097\/icb.0000000000001081","journal-title":"Retin Cases Brief Rep"},{"key":"11247_CR95","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2021-000889","volume":"7","author":"JS Heng","year":"2022","unstructured":"Heng JS, Kim JM, Jones DK, Stoessel KM, Weiss SA, Sznol M, Kluger HM, Walter SD, Silverstein NA, Pointdujour-Lim R (2022) Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic review. BMJ Open Ophthalmol 7:e000889. https:\/\/doi.org\/10.1136\/bmjophth-2021-000889","journal-title":"BMJ Open Ophthalmol"},{"key":"11247_CR96","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10633-020-09795-8","volume":"142","author":"L Poujade","year":"2021","unstructured":"Poujade L, Samaran Q, Mura F, Guillot B, Meunier I, Du-Thanh A (2021) Melanoma-associated retinopathy during pembrolizumab treatment probably controlled by intravitreal injections of dexamethasone. Doc Ophthalmol 142:257\u2013263. https:\/\/doi.org\/10.1007\/s10633-020-09795-8","journal-title":"Doc Ophthalmol"},{"key":"11247_CR97","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/WCO.0b013e328347b307","volume":"24","author":"J Panzer","year":"2011","unstructured":"Panzer J, Dalmau J (2011) Movement disorders in paraneoplastic and autoimmune disease. Curr Opin Neurol 24:346\u2013353. https:\/\/doi.org\/10.1097\/WCO.0b013e328347b307","journal-title":"Curr Opin Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11247-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11247-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11247-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T16:22:16Z","timestamp":1662999736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11247-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,2]]},"references-count":97,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["11247"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11247-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,2]]},"assertion":[{"value":"12 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}